Tardive Dyskinesia Associated with High-Dose Intravenous Metoclopramide
NEJM 315:518-519, Breitbart,W., 1986
Reye's Syndrome & Aspirin
BMJ 292:1543-1544, 15901986., Tarlow,M., 1986
Verapamil Potentiates Carbamazephine Neurotoxicity:A Clinically Important Inhibitory Interaction
Lancet 1:700-703, Macphee,G.A.,et al, 1986
Carbamazepine Neurotoxicity Precipitated by Dilitiazem
BMJ 292:1170-1171, Brodie,M.J.,et al, 1986
Glutamate & the Pathophysiology of Hypoxic-Ischemic Brain Damage
Ann Neurol 19:105-111, Rothman,S.M.&Olney,J.W., 1986
Aspirin:What Dose? Editorial
Lancet 1:592-593, , 1986
Parkinsonism, Tardive Dyskinesia, Akathisia, & Depression Induced by Flunarizine
Lancet 1:1303-1304, Chouza,C.,et al, 1986
Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985
Which Drug for the Adult Epileptic Patient:Phenytoin or Valproate
BMJ 290:815-819, Turnbull,D.M.,et al, 1985
Public Health Service Study on Reye's Syndrome & Medications, Report of the Pilot Phase
NEJM 313:849-857, Hurwitz,E.S.,et al, 1985
A Prospective Study Between Carbamazepine, Phenytoin & Sodium Valproate as Monotherapy in Untreated Epilepsy
JNNP 48:639-644, Callaghan,A.,et al, 1985
Naproxen in Prophylaxis of Migraine
Arch Neurol 42:582-584, Ziegler,D.K.,et al, 1985
Cyanide-Induced Parkinsonism:A Clinicopathologic Report
Neurol 35:921-925, Uitti,R.J.,et al, 1985
Association of High Cyanide & Low Sulphur Intake in Cassava-Induced Spastic Paraparesis
Lancet 2:1211-1213, Cliff,J.,et al, 1985
Persantine Aspirin Trial in Cerebral Ischemia Part II:Endpoint Results
The American-Canadian Co-Operative Study Group, Stroke 16:406-4151985., , 1985
Does Platelet Antiaggregant Therapy Lessen the Severity of Stroke
Neurol 35:632-636, Grotta,J.C.,et al, 1985
Thromboembolism in Patients with Atrial Fibrillation
Arch Neurol 41:708-710, Sherman,D.G.,et al, 1984
Metoclopramide & Tardive Dyskinesia in the Elderly
BMJ 289:397-398, Orme,M.L., 1984
Reye's Syndrome Associated with Long-Term Aspirin Therapy
JAMA 251:754-756, Young,R.S.K.,et al, 1984
Therapy of Ischemic Cerebral Vascular Disease Due to Atherothrombosis
NEJM 311:27-34, 100-1051984., Kistler,J.P.,et al, 1984
Antifibrinolytic Treatment in Subarachnoid Hemorrhage
NEJM 311:432-437, Vermeulen,M.,et al, 1984
Mitral Valve Prolapse & Cerebral Ischemic Events in Young Patients
Neurol 34:784-787, Jackson,A.C.,et al, 1984
Treatment after Transient Ischemic Attacks:A Comparison between Anticoagulant Drug & Inhibition of Platelet Aggrega
Stroke 14:677-681, Garde,A.,et al, 1983
Myoclonus Induced by Metoclopramide Therapy
Arch Int Med 143:2201-2202, Hyser,C.G.,et al, 1983
Valproate-Ethosuximide Combination Therapy for Refractory Absence Seizures
Arch Neurol 40:797-802, Rowan,A.J.,et al, 1983
Comparison of Valproic Acid & Phenytoin in Newly Diagnosed Tonic-Clonic Seizures
Neurol 33:1474-1476, Wilder,B.J.,et al, 1983
Effect of Carbamazepine on Coumadin Metabolism
Ann Neurol 13:691-692, Massey,E.W., 1983
"AICLA"Controlled Trial of Aspirin & Dipyridamole in the Prevention of Athero-Thrombotic Cerebral Ischemia
Stroke 14:5-14, Bousser,M.G.,et al, 1983
Acetylsalicylic Acid in the Prevention of Strokes in Patients with Reversible Cerebral Ischemic Attacks
Stroke 14:15-22, Sorensen,P.S.,et al, 1983
Hepatic & Cerebral Pathology Findings in Children with Fatal Salicylate Intoxication
Lancet 1:326-329, Starko,K.M.,et al, 1983
Serum Folate Concentra. During Pregnancy in Women with Epilepsy:Relation to Antiepileptic Drug Concentrations
BMJ 287:577-579, Hiilesmaa,V.K.,et al, 1983
Safe Readministration of Valproate after an Episode of Hepatotoxicity
Ann Neurol 13:688, Ramsay,R.E., 1983
Valproic Acid & Fetal Abnormality
BMJ 286:190, Bailey,C.J.,et al, 1983
Valproic Acid Therapy for Complex Partial Seizures, Its Efficacy & Toxic Effects
Arch Neurol 40:135-137, Bruni,J.,et al, 1983
Plasma Concentrations of Sodium Valproate:Their Clinical Value
Ann Neurol 14:38-42, Turnbull,D.M.,et al, 1983
Valproic Acid & Intractable Seizures in Severely Brain-Damaged Patients
Neurol 33:99-101, Chayasirisobhon,S.,et al, 1983
Adult Inorganic Lead Intoxication:Presentation of 31 New Cases & a Review of Recent Advances in the Literature
Medicine 62:221-247, Cullen,M.R.,et al, 1983
A Comparison of Phenytoin & Valproate in Previously Untreated Adult Epileptic Patients
JNNP 45:55-59, Turnbull,D.M.,et al, 1982
Valproate & Clonazepam in the Treatment of Severe Progressive Myoclonus Epilepsy
Arch Neurol 39:236-238, Iivanainen,M.,et al, 1982
Aspirin as a Risk Factor in Reye's Syndrome
JAMA 247:3089-3094, Waldman,R.J.,et al, 1982
Reye's Syndrome & Medication Use
JAMA 248:687-691, Halpin,T.J.,et al, 1982
Arterial Complications of Migraine Treatment with Methysergide & Parenteral Ergotamine
BMJ 285:260-261, Joyce,D.A.,et al, 1982
Metoclopramide-Induced Parkinsonism
Arch Neurol 39:494-496, Indo,T.,et al, 1982
Drug Interaction with Coumarin Derivative Anticoagulants
BMJ 285:274-275, Sharp,A.A., 1982
Serum Salicylate Concentrations In Reye's Disease
Lancet 1:191-193, Partin,J.S.,et al, 1982
Sodium Valproate-induced Hyperammonemia Without Clinical Hepatic Dysfunction
Neurol 32:206-208, Zaret,B.S.,et al, 1982
Pure Red Cell Aplasia Associated with Sodium Valproate Therapy
JAMA 247:53-54, MacDougall,L.G.,et al, 1982
Current Status of Antifibrinolytic Therapy for Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage
Jr. , Stroke 13:256-259982., Adams,H.P., 1982
Acute Akathisia After Oral Droperidol & Metoclopramide Preoperative Medication
Lancet 2:48-49, Barnes,T.R.E.,et al, 1982
Phenytoin-valproate Interaction:Importance of Saliva Monitoring in Epilepsy
BMJ 284:13-16, Knott,C.,et al, 1982